Skip to main content

Trafalgar International, Inc.

GCAND
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001695473

No open-market purchases or sales by Trafalgar International, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesGCAN

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding GCAND, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding GCAND at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Trafalgar International, Inc. insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Trafalgar International, Inc. insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in Trafalgar International, Inc. at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding GCAND in 13F filings for Q2 2026.